{"brief_title": "Study Evaluating Venlafaxine ER in Recurrent Depression", "brief_summary": "The purpose of this study is to review the long-term comparative efficacy of venlafaxine ER in achieving and sustaining remission (wellness) in patients with recurrent major depression", "condition": ["Depressive Disorder, Major", "Recurrence"], "intervention_type": ["Drug"], "intervention_name": ["Venlafaxine ER"], "criteria": "Inclusion Criteria - Clinical diagnosis for recurrent major depression Exclusion Criteria - The patient has failed on an adequate trial of fluoxetine, venlafaxine or venlafaxine ER during the current episode of major depression or the patient is treatment-resistant - Known hypersensitivity to venlafaxine or fluoxetine - History or presence of clinically significant hepatic, cardiovascular or renal disease, or other serious medical disease, including history of seizure disorder", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Depression", "mesh_term": ["Depression", "Depressive Disorder", "Recurrence", "Depressive Disorder, Major", "Venlafaxine Hydrochloride"], "id": "NCT00046020"}